Identification of genes that predict the response to chemotherapy with 5-azacytidine in myelodysplastic syndromes

被引：0
|
作者：
Matsumoto, Taichi [1 ,2 ]
Murakami, Yuichi [1 ]
Katsuchi, Daisuke [1 ]
Kuwano, Michihiko [1 ]
Ono, Mayumi [1 ,3 ]
机构：
[1] St Marys Inst Hlth Sci, Canc Transl Res Ctr, Fukuoka, Japan
[2] Fukuoka Univ, Dept Drug Inform, Pharm Sci, Fukuoka, Japan
[3] St Marys Coll, Grad Sch Nursing, Dept Pharm Oncol, Fukuoka, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2366
引用
收藏
页码：1261 / 1261
页数：1
相关论文
共 50 条
  • [21] In vitro preclinical assessment of alvocidib in combination with 5-azacytidine in higher-risk myelodysplastic syndromes
    Riabov, V
    Xu, Q.
    Schmitt, N.
    Streuer, A.
    Jann, J. -C
    Wein, A.
    Altrock, E.
    Mehralivand, A.
    Nowak, V
    Weimer, N.
    Oblaender, J.
    Palme, I
    Jawhar, A.
    Weiss, C.
    Metzgeroth, G.
    Foulks, J. M.
    Hofmann, W-K
    Nowak, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 99 - 99
  • [22] Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome
    Diamantopoulos, Panagiotis T.
    Kontandreopoulou, Christina-Nefeli
    Symeonidis, Argiris
    Kotsianidis, Ioannis
    Pappa, Vassiliki
    Galanopoulos, Athanasios
    Vassilakopoulos, Theodoros
    Dimou, Maria
    Solomou, Eleni
    Kyrtsonis, Marie-Christine
    Siakantaris, Marina
    Angelopoulou, Maria
    Kourakli, Alexandra
    Papageorgiou, Sotirios
    Christopoulou, Georgia
    Roumelioti, Maria
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1383 - 1392
  • [23] Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome
    Panagiotis T. Diamantopoulos
    Christina-Nefeli Kontandreopoulou
    Argiris Symeonidis
    Ioannis Kotsianidis
    Vassiliki Pappa
    Athanasios Galanopoulos
    Theodoros Vassilakopoulos
    Maria Dimou
    Eleni Solomou
    Marie-Christine Kyrtsonis
    Marina Siakantaris
    Maria Angelopoulou
    Alexandra Kourakli
    Sotirios Papageorgiou
    Georgia Christopoulou
    Maria Roumelioti
    Panayiotis Panayiotidis
    Nora-Athina Viniou
    Annals of Hematology, 2019, 98 : 1383 - 1392
  • [24] Bone Marrow Levels of PARP1 mRNA Predict Response to Treatment with 5-Azacytidine in Patients with Myelodysplastic Syndrome
    Diamantopoulos, Panagiotis Theodorou
    Kodandreopoulou, Elina
    Symeonidis, Argiris S.
    Kotsianidis, Ioannis
    Pappa, Vassiliki
    Galanopoulos, Athanasios
    Dimou, Maria
    Christopoulou, Georgia
    Zervakis, Konstantinos
    Solomou, Elena E.
    Kyrtsonis, Marie-Christine
    Rougala, Niki
    Siakantaris, Marina
    Vassilakopoulos, Theodoros
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    BLOOD, 2017, 130
  • [25] Treatment of Poor Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia with a Combination of 5-Azacytidine and Valproic Acids
    Kuendgen, Andrea
    Bug, Gesine
    Ottmann, Oliver G.
    Haase, Detlef
    Hildebrandt, Barbara
    Habersang, Kerstin
    Dienst, Ariane
    Haas, Rainer
    Germing, Ulrich
    Gattermann, Norbert
    BLOOD, 2008, 112 (11) : 1245 - 1245
  • [26] Autoimmune hematological manifestations in myelodysplastic sindromes responding to 5-azacytidine
    Magrin, S.
    Malato, A.
    Bica, M. G.
    Di Bella, R.
    Salemi, D.
    Fabbiano, F.
    Acquaviva, F.
    LEUKEMIA RESEARCH, 2013, 37 : S168 - S168
  • [27] Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
    Andrea Kuendgen
    Gesine Bug
    Oliver G. Ottmann
    Detlef Haase
    Julie Schanz
    Barbara Hildebrandt
    Kathrin Nachtkamp
    Judith Neukirchen
    Ariane Dienst
    Rainer Haas
    Ulrich Germing
    Norbert Gattermann
    Clinical Epigenetics, 2011, 2 : 389 - 399
  • [28] Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes
    Matsumoto, Taichi
    Murakami, Yuichi
    Yoshida-Sakai, Nao
    Katsuchi, Daisuke
    Kanazawa, Kuon
    Okamura, Takashi
    Imamura, Yutaka
    Ono, Mayumi
    Kuwano, Michihiko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [29] 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes
    Anja L. Gawlitza
    Johanna Speith
    Jenny Rinke
    Roman Sajzew
    Elena K. Müller
    Vivien Schäfer
    Andreas Hochhaus
    Thomas Ernst
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2835 - 2843
  • [30] Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes
    Voso, Maria Teresa
    Santini, Valeria
    Finelli, Carlo
    Musto, Pellegrino
    Pogliani, Enrico
    Angelucci, Emanuele
    Fioritoni, Giuseppe
    Alimena, Giuliana
    Maurillo, Luca
    Cortelezzi, Agostino
    Buccisano, Francesco
    Gobbi, Marco
    Borin, Lorenza
    Di Tucci, Anna
    Zini, Gina
    Petti, Maria Concetta
    Martinelli, Giovanni
    Fabiani, Emiliano
    Fazi, Paola
    Vignetti, Marco
    Piciocchi, Alfonso
    Liso, Vincenzo
    Amadori, Sergio
    Leone, Giuseppe
    CLINICAL CANCER RESEARCH, 2009, 15 (15) : 5002 - 5007
12345